# FDA Inspection 1283116 - B Positive National Blood Services - September 12, 2025

Source: https://www.keypedia.com/records/fda_inspections/b-positive-national-blood-services/bd3daccb-30e3-49a4-ba8e-68e31b734263
Source feed: FDA_Inspections

> FDA Inspection 1283116 for B Positive National Blood Services on September 12, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283116
- Company Name: B Positive National Blood Services
- Inspection Date: 2025-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1283116 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/b-positive-national-blood-services/7048b3a9-5d72-481e-956a-27c8a9babe0e)

Company: https://www.keypedia.com/companies/b-positive-national-blood-services/60e064e8-74d5-4b62-8ed1-9761eca22bd3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d